90 results
DEFA14A
ONCR
Oncorus, Inc.
3 Aug 23
Additional proxy soliciting materials
4:38pm
Securities Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks
8-K
ONCR
Oncorus, Inc.
3 Aug 23
Departure of Directors or Certain Officers
4:36pm
Private Securities Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends
DEFA14A
ONCR
Oncorus, Inc.
28 Jul 23
Additional proxy soliciting materials
4:40pm
harbor provisions of the United States Private Securities Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates
8-K
ONCR
Oncorus, Inc.
28 Jul 23
Departure of Directors or Certain Officers
4:12pm
Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may
PRE 14A
u0ld5z
12 Jun 23
Preliminary proxy
6:33am
8-K
rkuxnx4e xkumi
7 Jun 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-99.1
3753q61y92sox5lf
1 Jun 23
Oncorus Announces Workforce Reduction Plan
4:34pm
8-K
EX-99.1
dzpy6q uk9ror77y
22 May 23
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
4:13pm
8-K
0zgam
30 Nov 22
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
7:07am
8-K
EX-99.1
twuums0
30 Nov 22
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
7:07am
8-K
EX-99.1
b4yixg6g1gg1ky1ccd
2 Nov 22
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:11am
8-K
EX-99.1
r8b33g3ulo0ki h2
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
8-K
EX-99.1
vd1ch614
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am